This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burk, R. F. Articles by Byrne, D. W. Search for Related Content PubMed PubMed Citation Articles by Burk, R. F. Articles by Byrne, D. W. Related Collections Clinical Intervention Clinical Intervention: Biomarkers

Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial

¹ Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, and ² Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee

Requests for reprints: Raymond F. Burk, 1030C Medical Research Building IV, Vanderbilt Medical Center, Nashville, TN 37232-0252. E-mail: raymond.burk{at}vanderbilt.edu

Intervention trials with different forms of selenium are under way to assess the effects of selenium supplements on the incidence of cancer and other diseases. Plasma selenium biomarkers respond to selenium administration and might be useful for assessing compliance and safety in these trials. The present study characterized the effects of selenium supplementation on plasma selenium biomarkers and urinary selenium excretion in selenium-replete subjects. Moderate (200 µg/d) to large (600 µg/d) selenium supplements in the forms sodium selenite, high-selenium yeast (yeast), and L-selenomethionine (selenomethionine) were administered. Subjects were randomized into 10 groups (placebo and three dose levels of each form of selenium). Plasma biomarkers (selenium concentration, selenoprotein P concentration, and glutathione peroxidase activity) were determined before supplementation and every 4 weeks for 16 weeks. Urinary selenium excretion was determined at 16 weeks. Supplementation with selenomethionine and yeast raised the plasma selenium concentration in a dose-dependent manner. Selenite did not. The increased selenium concentration correlated with the amount of selenomethionine administered. Neither glutathione peroxidase activity nor selenoprotein P concentration responded to selenium supplementation. Urinary selenium excretion was greater after selenomethionine than after selenite, with excretion after yeast being intermediate and not significantly different from either of the other two. We conclude that plasma selenium concentration is useful in monitoring compliance and safety of selenium supplementation as selenomethionine but not as selenite. Plasma selenium seems to reflect the selenomethionine content of yeast but not the other yeast selenium forms. As judged by urinary selenium excretion, selenium in the form of selenomethionine is better absorbed than selenite. (Cancer Epidemiol Biomarkers Prev 2006;15(4):804–10)

This article has been cited by other articles:

				V. Pagmantidis, C. Meplan, E. M van Schothorst, J. Keijer, and J. E Hesketh Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes Am. J. Clinical Nutrition, January 1, 2008; 87(1): 181 - 189. [Abstract] [Full Text] [PDF]

				C. Meplan, L. K. Crosley, F. Nicol, G. J. Beckett, A. F. Howie, K. E. Hill, G. Horgan, J. C. Mathers, J. R. Arthur, and J. E. Hesketh Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study) FASEB J, October 1, 2007; 21(12): 3063 - 3074. [Abstract] [Full Text] [PDF]

				T. M. Vogt, R. G. Ziegler, B. H. Patterson, and B. I. Graubard Racial Differences in Serum Selenium Concentration: Analysis of US Population Data from the Third National Health and Nutrition Examination Survey Am. J. Epidemiol., August 1, 2007; 166(3): 280 - 288. [Abstract] [Full Text] [PDF]

				S. O Shaheen, R. B Newson, M. P Rayman, A. P-L Wong, M. K Tumilty, J. M Phillips, J. F Potts, F. J Kelly, P. T White, and P. G J Burney Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma Thorax, June 1, 2007; 62(6): 483 - 490. [Abstract] [Full Text] [PDF]

				G. Flores-Mateo, A. Navas-Acien, R. Pastor-Barriuso, and E. Guallar Selenium and coronary heart disease: a meta-analysis. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 762 - 773. [Abstract] [Full Text] [PDF]